Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
Episodes 1-15 of 227
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Project Oncology®Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerBalancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
On the Frontlines of Metastatic Breast CancerNavigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Advances in Chronic GVHD Care: Insights from the AGAVE-201 Trial
Project Oncology®Advances in Chronic GVHD Care: Insights from the AGAVE-201 Trial
Targeting CD123 in AML: The Latest Therapeutic Advancements
Project Oncology®Targeting CD123 in AML: The Latest Therapeutic Advancements
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Project Oncology®Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
Project Oncology®Advancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Clinician's RoundtableEtranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Spotlight On Subcutaneous Cancer ImmunotherapiesAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Project Oncology®Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Project Oncology®AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Spotlight On Subcutaneous Cancer ImmunotherapiesNanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Spotlight On Subcutaneous Cancer ImmunotherapiesEvaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Project Oncology®Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Project Oncology®The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
